Free Trial
→ Watch This Robotics Demo Before July 23rd (From Brownstone Research) (Ad) Buy LMAT Stock  Free LMAT Stock Alerts

LeMaitre Vascular (LMAT) Financials

LeMaitre Vascular logo
$80.44 +1.74 (+2.21%)
Closing price 05/5/2025 04:00 PM Eastern
Extended Trading
$76.69 -3.75 (-4.66%)
As of 05:01 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Compare
Annual Income Statements for LeMaitre Vascular

Annual Income Statements for LeMaitre Vascular

This table shows LeMaitre Vascular's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 3.92 7.76 11 17 23 18 21 27 21 30 44
Consolidated Net Income / (Loss)		 3.92 7.76 11 17 23 18 21 27 21 30 44
Net Income / (Loss) Continuing Operations		 3.92 7.76 11 17 23 18 21 27 21 30 44
Total Pre-Tax Income 		6.32 11 16 21 28 22 27 34 27 39 57
Total Operating Income		 6.34 12 16 21 28 21 29 36 27 37 52
Total Gross Profit		 48 54 63 71 74 80 85 101 105 127 151
Total Revenue		 71 78 89 101 106 117 129 154 162 193 220
Operating Revenue		 71 78 89 101 106 117 129 154 162 193 220
Total Cost of Revenue		 23 24 26 30 32 37 45 53 57 66 69
Operating Cost of Revenue		 23 24 26 30 32 37 45 53 57 66 69
Total Operating Expenses		 42 43 47 50 46 59 56 65 78 90 99
Selling, General & Admin Expense		 14 14 14 17 18 19 23 26 29 32 36
Marketing Expense		 22 23 26 26 27 30 24 28 33 41 47
Research & Development Expense		 4.67 5.48 6.14 6.64 8.20 9.28 10 12 13 17 16
Total Other Income / (Expense), net		 -0.02 -0.09 -0.09 0.00 0.24 0.50 -1.43 -2.14 0.66 2.76 4.62
Interest Expense		 0.01 - 0.01 0.02 0.00 0.00 1.31 2.22 0.00 0.00 0.21
Interest & Investment Income		 0.00 0.01 0.08 0.18 0.63 0.70 0.21 0.20 0.99 3.08 4.95
Other Income / (Expense), net		 -0.02 -0.10 -0.16 -0.16 -0.39 -0.20 -0.33 -0.12 -0.33 -0.31 -0.13
Income Tax Expense		 2.41 3.67 5.65 3.93 5.50 3.75 6.14 7.38 6.85 9.37 13
Basic Earnings per Share		 $0.24 $0.44 $0.57 $0.91 $1.18 $0.91 $1.05 $1.27 $0.94 $1.36 $1.96
Weighted Average Basic Shares Outstanding		 16.61M 17.76M 18.49M 18.96M 19.43M 19.81M 20.25M 21.16M 21.98M 22.22M 22.45M
Diluted Earnings per Share		 $0.23 $0.42 $0.55 $0.86 $1.13 $0.88 $1.04 $1.25 $0.93 $1.34 $1.93
Weighted Average Diluted Shares Outstanding		 17.01M 18.32M 19.24M 20.03M 20.24M 20.33M 20.48M 21.48M 22.17M 22.42M 22.78M
Weighted Average Basic & Diluted Shares Outstanding		 16.30M 17.60M 18.60M 18.90M 18.67M 20.18M 20.53M 21.93M 22.10M 22.34M 22.56M
Cash Dividends to Common per Share		 $0.14 $0.16 $0.18 $0.22 $0.28 $0.34 $0.38 $0.44 $0.50 $0.56 $0.64

Quarterly Income Statements for LeMaitre Vascular

This table shows LeMaitre Vascular's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Income / (Loss) Attributable to Common Shareholders		 5.46 5.63 6.04 8.10 7.50 8.47 9.89 12 11 11
Consolidated Net Income / (Loss)		 5.46 5.63 6.04 8.10 7.50 8.47 9.89 12 11 11
Net Income / (Loss) Continuing Operations		 5.46 5.63 6.04 8.10 7.50 8.47 9.89 12 11 11
Total Pre-Tax Income 		6.15 7.80 8.02 10 9.83 11 13 16 15 14
Total Operating Income		 6.15 6.97 7.87 9.45 9.18 10 12 14 13 13
Total Gross Profit		 25 26 31 32 31 33 37 38 37 39
Total Revenue		 39 41 47 50 47 49 53 56 55 56
Operating Revenue		 39 41 47 50 47 49 53 56 55 56
Total Cost of Revenue		 14 15 16 18 17 16 17 17 18 17
Operating Cost of Revenue		 14 15 16 18 17 16 17 17 18 17
Total Operating Expenses		 19 19 23 23 22 23 25 24 24 26
Selling, General & Admin Expense		 7.23 6.93 7.93 7.72 7.74 8.44 9.01 8.82 8.93 9.49
Marketing Expense		 8.23 8.60 11 10 9.67 10 12 11 11 13
Research & Development Expense		 3.46 3.55 3.88 4.52 4.22 4.35 4.09 4.28 3.66 3.62
Total Other Income / (Expense), net		 -0.00 0.83 0.14 0.87 0.65 1.11 0.92 1.13 1.40 1.17
Interest & Investment Income		 0.26 0.45 0.57 0.68 0.84 0.99 1.00 1.14 1.20 1.61
Other Income / (Expense), net		 -0.27 0.38 -0.43 0.19 -0.19 0.12 -0.08 -0.01 0.20 -0.24
Income Tax Expense		 0.69 2.17 1.98 2.22 2.32 2.85 2.91 3.68 3.41 2.84
Basic Earnings per Share		 $0.25 $0.25 $0.27 $0.36 $0.34 $0.39 $0.44 $0.53 $0.50 $0.49
Weighted Average Basic Shares Outstanding		 21.98M 21.98M 22.11M 22.21M 22.26M 22.22M 22.37M 22.46M 22.48M 22.45M
Diluted Earnings per Share		 $0.25 $0.25 $0.27 $0.36 $0.33 $0.38 $0.44 $0.52 $0.49 $0.48
Weighted Average Diluted Shares Outstanding		 22.22M 22.17M 22.27M 22.45M 22.48M 22.42M 22.57M 22.73M 22.84M 22.78M
Weighted Average Basic & Diluted Shares Outstanding		 22.00M 22.10M 22.16M 22.26M 22.26M 22.34M 22.45M 22.47M 22.48M 22.56M
Cash Dividends to Common per Share		 $0.13 $0.13 $0.14 $0.14 $0.14 $0.14 $0.16 $0.16 $0.16 $0.16

Annual Cash Flow Statements for LeMaitre Vascular

This table details how cash moves in and out of LeMaitre Vascular's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Net Change in Cash & Equivalents		 3.98 8.76 -3.16 -5.19 7.22 -15 15 65 5.28 5.14 -0.39
Net Cash From Operating Activities		 5.51 11 17 23 20 14 35 35 25 37 44
Net Cash From Continuing Operating Activities		 5.51 11 17 23 20 14 35 35 25 37 44
Net Income / (Loss) Continuing Operations		 3.92 7.76 11 17 23 18 21 27 21 30 44
Consolidated Net Income / (Loss)		 3.92 7.76 11 17 23 18 21 27 21 30 44
Depreciation Expense		 3.33 3.39 3.59 4.06 4.32 5.42 8.40 11 9.43 9.52 9.67
Non-Cash Adjustments To Reconcile Net Income		 2.23 1.36 2.21 2.85 -3.93 3.72 4.47 7.68 9.02 7.68 11
Changes in Operating Assets and Liabilities, net		 -3.97 -1.07 0.51 -1.22 -3.83 -13 0.72 -11 -14 -11 -20
Net Cash From Investing Activities		 -7.75 -3.48 -17 -29 -7.06 -24 -53 -61 -10 -25 -200
Net Cash From Continuing Investing Activities		 -7.75 -3.48 -17 -29 -7.06 -24 -53 -61 -10 -25 -200
Purchase of Property, Plant & Equipment		 -1.17 -2.27 -2.84 -6.42 -3.05 -3.76 -2.98 -4.88 -3.23 -7.27 -6.96
Acquisitions		 -6.57 -1.58 -14 0.00 -12 -21 -73 0.00 0.00 -0.90 0.00
Purchase of Investments		 - - 0.00 -23 -20 -23 -2.21 -59 -8.00 -17 -278
Sale of Property, Plant & Equipment		 - 0.02 - - 0.00 0.00 2.02 0.00 0.86 0.00 0.00
Sale and/or Maturity of Investments		 - - 0.00 0.00 21 24 23 3.00 0.00 0.00 85
Net Cash From Financing Activities		 6.66 1.08 -2.58 0.08 -4.42 -4.62 32 14 -9.23 -7.13 158
Net Cash From Continuing Financing Activities		 6.66 1.08 -2.58 0.08 -4.42 -4.62 32 92 -9.23 -7.13 156
Repayment of Debt		 -1.13 - - - 0.00 0.00 -28 39 0.00 0.00 -3.23
Repurchase of Common Equity		 -0.21 -0.27 -0.31 -0.78 -0.74 -0.68 -0.57 -0.80 -0.64 -0.85 -1.72
Payment of Dividends		 -2.31 -2.85 -3.32 -4.18 -5.45 -6.74 -7.70 -9.34 -11 -12 -14
Issuance of Debt		 - - - - 0.00 0.00 65 - 0.00 0.00 169
Issuance of Common Equity		 11 4.84 1.44 5.50 2.97 4.86 5.97 63 3.47 6.17 6.44
Other Financing Activities, net		 -0.52 -0.65 -0.39 -0.46 -1.20 -2.06 -2.80 -0.40 -1.07 0.00 0.00
Effect of Exchange Rate Changes		 -0.45 -0.28 -0.27 0.82 - - 0.91 - - - -0.77

Quarterly Cash Flow Statements for LeMaitre Vascular

This table details how cash moves in and out of LeMaitre Vascular's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Net Change in Cash & Equivalents		 -3.88 2.22 -2.46 2.81 -1.44 6.22 2.33 -4.33 -1.27 2.88
Net Cash From Operating Activities		 7.34 4.08 2.28 12 12 11 5.07 9.63 14 15
Net Cash From Continuing Operating Activities		 7.34 4.29 2.28 12 12 11 5.07 9.63 14 15
Net Income / (Loss) Continuing Operations		 5.46 5.63 6.04 8.10 7.50 8.47 9.89 12 11 11
Consolidated Net Income / (Loss)		 5.46 5.63 6.04 8.10 7.50 8.47 9.89 12 11 11
Depreciation Expense		 2.33 2.29 2.35 2.33 2.40 2.44 2.38 2.38 2.43 2.48
Non-Cash Adjustments To Reconcile Net Income		 1.93 2.04 1.98 1.92 2.01 1.77 2.64 2.91 2.11 3.17
Changes in Operating Assets and Liabilities, net		 -2.37 -5.67 -8.09 -0.44 -0.09 -1.93 -9.84 -7.50 -1.43 -1.65
Net Cash From Investing Activities		 -8.46 -0.40 -2.96 -9.64 -9.85 -2.26 -2.36 -11 -13 -174
Net Cash From Continuing Investing Activities		 -8.46 -0.40 -2.96 -9.64 -9.85 -2.26 -2.36 -11 -13 -174
Purchase of Property, Plant & Equipment		 -0.46 -1.26 -2.13 -2.80 -1.05 -1.28 -1.37 -1.88 -1.67 -2.04
Purchase of Investments		 -8.00 - -0.56 -6.68 -8.33 -0.98 -0.99 -9.13 -11 -257
Net Cash From Financing Activities		 -2.15 -2.12 -1.83 0.50 -3.12 -2.69 0.04 -2.87 -3.15 164
Net Cash From Continuing Financing Activities		 -2.15 -2.12 -1.83 0.50 -3.12 -2.69 0.04 -2.87 -3.15 162
Repurchase of Common Equity		 -0.00 -0.49 -0.17 -0.01 -0.01 -0.67 -0.36 -0.01 -0.00 -1.35
Payment of Dividends		 -2.75 -2.75 -3.10 -3.12 -3.12 -3.12 -3.59 -3.59 -3.60 -3.60
Other Financing Activities, net		 - -0.67 1.45 3.63 - -5.07 3.99 0.73 0.45 -5.17

Annual Balance Sheets for LeMaitre Vascular

This table presents LeMaitre Vascular's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Total Assets		 81 91 102 126 153 188 253 293 310 347 552
Total Current Assets		 49 58 59 80 94 92 94 140 162 195 402
Cash & Equivalents		 19 27 24 19 26 12 27 14 19 24 26
Short-Term Investments		 - - - 23 22 21 0.21 56 64 81 274
Accounts Receivable		 11 12 13 15 16 17 20 20 22 25 30
Inventories, net		 17 15 20 21 27 40 45 46 50 58 65
Prepaid Expenses		 2.38 3.56 1.97 2.61 2.92 3.31 2.62 4.19 6.73 6.38 7.48
Plant, Property, & Equipment, net		 6.88 7.02 8.01 12 14 15 15 17 18 22 25
Total Noncurrent Assets		 26 25 35 34 45 81 144 136 131 130 125
Goodwill		 17 18 23 24 30 40 66 66 66 66 66
Intangible Assets		 7.16 6.34 9.90 8.23 14 25 59 53 47 42 36
Noncurrent Deferred & Refundable Income Taxes		 1.42 1.21 1.40 1.38 1.22 1.08 1.69 1.57 1.75 1.00 1.43
Other Noncurrent Operating Assets		 0.17 0.17 0.16 0.18 0.19 15 17 16 17 22 22
Total Liabilities & Shareholders' Equity		 81 91 102 126 153 188 253 293 310 347 552
Total Liabilities		 13 13 14 17 23 40 80 39 42 49 215
Total Current Liabilities		 10 10 10 13 20 21 25 22 25 30 31
Accounts Payable		 1.13 1.37 1.22 1.54 1.73 2.60 2.39 2.34 2.90 3.73 1.76
Accrued Expenses		 7.48 8.84 8.80 9.77 16 14 18 16 20 24 25
Other Current Liabilities		 1.44 0.17 0.46 1.88 2.18 4.23 2.73 3.14 2.46 2.50 4.11
Total Noncurrent Liabilities		 3.24 2.45 3.94 3.36 3.10 19 55 17 17 19 184
Long-Term Debt		 - - - - - 0.00 36 - - 0.00 168
Noncurrent Deferred & Payable Income Tax Liabilities		 2.92 1.68 1.94 2.18 0.48 1.18 0.13 0.07 0.07 0.11 0.09
Other Noncurrent Operating Liabilities		 0.33 0.77 2.00 1.19 2.61 18 19 17 17 19 16
Commitments & Contingencies		 0.00 - - - - - - - - 0.00 0.00
Total Equity & Noncontrolling Interests		 68 78 88 110 130 148 173 254 268 298 337
Total Preferred & Common Equity		 68 78 88 110 130 148 173 254 268 298 337
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 68 78 88 110 130 148 173 254 268 298 337
Common Stock		 76 82 86 93 99 106 115 182 190 201 214
Retained Earnings		 3.25 8.16 15 28 46 57 71 88 98 115 145
Treasury Stock		 -8.25 -8.52 -8.83 -9.61 -10 -11 -12 -12 -13 -14 -16
Accumulated Other Comprehensive Income / (Loss)		 -2.37 -4.05 -4.58 -2.29 -3.90 -4.01 -1.53 -3.44 -6.03 -4.63 -6.18

Quarterly Balance Sheets for LeMaitre Vascular

This table presents LeMaitre Vascular's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q3 2022 Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024
Period end date 9/30/2022 3/31/2023 6/30/2023 9/30/2023 3/31/2024 6/30/2024 9/30/2024
Total Assets		 302 315 326 334 354 363 377
Total Current Assets		 153 165 174 182 203 213 227
Cash & Equivalents		 17 17 19 18 27 22 21
Short-Term Investments		 63 64 71 79 82 91 103
Accounts Receivable		 20 25 26 24 30 31 32
Inventories, net		 48 54 54 56 61 64 65
Prepaid Expenses		 4.84 4.62 4.08 5.10 3.86 5.22 5.94
Plant, Property, & Equipment, net		 15 19 21 21 22 23 24
Total Noncurrent Assets		 134 131 131 130 129 127 126
Goodwill		 66 66 66 66 66 66 66
Intangible Assets		 48 46 44 43 40 39 37
Noncurrent Deferred & Refundable Income Taxes		 2.79 1.80 2.08 2.33 0.83 1.03 1.31
Other Noncurrent Operating Assets		 17 18 19 19 22 21 21
Total Liabilities & Shareholders' Equity		 302 315 326 334 354 363 377
Total Liabilities		 41 41 43 45 45 44 46
Total Current Liabilities		 23 24 26 29 27 25 29
Accounts Payable		 2.85 3.37 3.52 4.37 3.09 2.00 1.65
Accrued Expenses		 17 18 19 22 21 21 23
Other Current Liabilities		 3.19 2.91 3.01 2.87 2.60 2.67 4.20
Total Noncurrent Liabilities		 17 17 17 16 19 18 17
Noncurrent Deferred & Payable Income Tax Liabilities		 0.06 0.07 0.07 0.07 0.11 0.10 0.11
Other Noncurrent Operating Liabilities		 17 17 17 16 19 18 16
Total Equity & Noncontrolling Interests		 261 274 284 289 309 320 331
Total Preferred & Common Equity		 261 274 284 289 309 320 331
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 261 274 284 289 309 320 331
Common Stock		 187 192 197 198 207 209 211
Retained Earnings		 95 101 106 110 122 130 138
Treasury Stock		 -13 -13 -13 -13 -14 -14 -14
Accumulated Other Comprehensive Income / (Loss)		 -8.13 -5.57 -5.82 -6.71 -5.56 -5.09 -3.16

Annual Metrics and Ratios for LeMaitre Vascular

This table displays calculated financial ratios and metrics derived from LeMaitre Vascular's official financial filings.

Metric 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024
Period end date 12/31/2014 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 10.14% 10.20% 13.78% 13.14% 4.66% 11.05% 10.35% 19.37% 4.68% 19.69% 13.63%
EBITDA Growth		 35.47% 53.29% 33.51% 26.50% 28.54% -17.87% 39.61% 28.56% -24.15% 27.76% 34.60%
EBIT Growth		 45.85% 80.44% 41.75% 29.51% 32.78% -24.57% 35.64% 27.58% -27.00% 37.33% 43.22%
NOPAT Growth		 17.50% 99.07% 36.23% 61.24% 32.48% -22.98% 27.43% 28.01% -29.54% 39.02% 44.52%
Net Income Growth		 22.27% 98.16% 36.50% 62.20% 33.57% -21.83% 18.32% 26.80% -23.31% 45.89% 46.28%
EPS Growth		 15.00% 82.61% 30.95% 56.36% 31.40% -22.12% 18.18% 20.19% -25.60% 44.09% 44.03%
Operating Cash Flow Growth		 2.30% 107.51% 47.72% 35.35% -14.70% -27.31% 145.43% 0.87% -27.70% 44.81% 20.06%
Free Cash Flow Firm Growth		 -80.65% 284.67% -130.83% 676.98% -29.83% -282.10% -192.18% 161.13% -32.82% 9.88% 35.13%
Invested Capital Growth		 18.31% 1.85% 25.34% 7.75% 20.76% 40.38% 59.04% 0.31% 0.72% 3.94% 6.49%
Revenue Q/Q Growth		 1.09% 2.35% 3.25% 2.92% 2.16% 1.54% 6.05% 1.28% 0.91% 4.27% 3.21%
EBITDA Q/Q Growth		 21.27% 2.93% 3.83% 11.63% 2.98% -6.33% 17.64% -1.78% -4.10% 7.30% 3.92%
EBIT Q/Q Growth		 33.90% 3.97% 4.48% 13.24% 2.97% -8.74% 18.45% -3.22% -3.42% 8.88% 4.61%
NOPAT Q/Q Growth		 41.61% 7.68% 1.40% 10.41% 8.04% -8.28% 16.04% -3.49% -6.84% 10.31% 6.92%
Net Income Q/Q Growth		 42.62% 8.59% 0.64% 10.89% 8.21% -7.30% 12.87% -3.09% -2.59% 10.41% 6.58%
EPS Q/Q Growth		 43.75% 5.00% 0.00% 11.69% 7.62% -7.37% 11.83% -5.30% -2.11% 10.74% 5.46%
Operating Cash Flow Q/Q Growth		 31.68% 12.19% 1.62% 12.69% -1.01% -6.45% 32.61% -20.58% -3.71% 22.17% 11.18%
Free Cash Flow Firm Q/Q Growth		 11.57% 26.17% -123.58% 1,323.68% -13.32% -1,214.60% 33.98% -16.94% -14.75% 35.44% 25.46%
Invested Capital Q/Q Growth		 1.54% -0.25% 21.47% -0.71% 3.17% 18.52% -1.32% 1.22% 2.20% 0.63% -0.89%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 68.12% 69.13% 70.59% 70.09% 70.04% 68.12% 65.41% 65.65% 64.89% 65.66% 68.63%
EBITDA Margin		 13.58% 18.90% 22.17% 24.79% 30.44% 22.52% 28.49% 30.68% 22.23% 23.73% 28.11%
Operating Margin		 8.92% 14.69% 18.32% 20.92% 26.72% 18.07% 22.25% 23.59% 16.60% 18.97% 23.77%
EBIT Margin		 8.89% 14.56% 18.14% 20.77% 26.35% 17.90% 22.00% 23.51% 16.40% 18.81% 23.71%
Profit (Net Income) Margin		 5.51% 9.90% 11.88% 17.03% 21.73% 15.30% 16.40% 17.42% 12.77% 15.56% 20.03%
Tax Burden Percent		 61.95% 67.91% 65.20% 81.38% 80.66% 82.73% 77.57% 78.48% 75.07% 76.26% 77.43%
Interest Burden Percent		 99.94% 100.11% 100.41% 100.75% 102.26% 103.33% 96.12% 94.43% 103.72% 108.45% 109.10%
Effective Tax Rate		 38.05% 32.09% 34.80% 18.62% 19.34% 17.27% 22.43% 21.52% 24.93% 23.74% 22.57%
Return on Invested Capital (ROIC)		 8.60% 15.65% 18.74% 26.16% 30.27% 17.73% 14.93% 15.54% 10.90% 14.80% 20.32%
ROIC Less NNEP Spread (ROIC-NNEP)		 8.67% 15.91% 18.98% 26.15% 29.84% 16.71% 25.21% 21.24% 10.25% 12.56% 17.31%
Return on Net Nonoperating Assets (RNNOA)		 -2.32% -5.02% -5.94% -8.74% -11.15% -4.84% -1.70% -2.93% -2.99% -4.16% -6.46%
Return on Equity (ROE)		 6.28% 10.62% 12.81% 17.41% 19.12% 12.88% 13.23% 12.61% 7.90% 10.64% 13.87%
Cash Return on Invested Capital (CROIC)		 -8.18% 13.81% -3.74% 18.70% 11.46% -15.87% -30.65% 15.24% 10.18% 10.93% 14.04%
Operating Return on Assets (OROA)		 8.32% 13.25% 16.79% 18.36% 19.91% 12.29% 12.90% 13.31% 8.79% 11.08% 11.60%
Return on Assets (ROA)		 5.15% 9.01% 11.00% 15.05% 16.42% 10.51% 9.62% 9.86% 6.84% 9.16% 9.80%
Return on Common Equity (ROCE)		 6.28% 10.62% 12.81% 17.41% 19.12% 12.88% 13.23% 12.61% 7.90% 10.64% 13.87%
Return on Equity Simple (ROE_SIMPLE)		 5.74% 9.96% 12.10% 15.65% 17.62% 12.11% 12.30% 10.59% 7.69% 10.11% 13.06%
Net Operating Profit after Tax (NOPAT)		 3.93 7.82 11 17 23 18 22 29 20 28 40
NOPAT Margin		 5.52% 9.98% 11.95% 17.03% 21.55% 14.95% 17.26% 18.51% 12.46% 14.47% 18.40%
Net Nonoperating Expense Percent (NNEP)		 -0.07% -0.26% -0.24% 0.01% 0.42% 1.02% -10.27% -5.70% 0.65% 2.24% 3.02%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - 7.51% 9.40% 8.01%
Cost of Revenue to Revenue		 31.88% 30.87% 29.41% 29.91% 29.96% 31.88% 34.59% 34.35% 35.11% 34.34% 31.37%
SG&A Expenses to Revenue		 19.54% 17.88% 16.10% 16.86% 16.76% 16.25% 17.39% 16.51% 17.78% 16.45% 16.49%
R&D to Revenue		 6.57% 6.99% 6.89% 6.58% 7.76% 7.91% 7.81% 7.64% 8.22% 8.77% 7.12%
Operating Expenses to Revenue		 59.20% 54.44% 52.27% 49.17% 43.32% 50.05% 43.16% 42.06% 48.29% 46.69% 44.87%
Earnings before Interest and Taxes (EBIT)		 6.32 11 16 21 28 21 28 36 27 36 52
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 9.66 15 20 25 32 26 37 47 36 46 62
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 1.76 3.68 4.99 5.22 3.35 0.46 4.61 4.20 3.71 4.21 6.14
Price to Tangible Book Value (P/TBV)		 2.75 5.33 8.06 7.38 5.03 0.82 16.66 7.88 6.38 6.59 8.80
Price to Revenue (P/Rev)		 1.69 3.66 4.90 5.68 4.13 0.58 6.14 6.91 6.15 6.48 9.42
Price to Earnings (P/E)		 30.70 36.97 41.24 33.36 19.01 3.80 37.46 39.67 48.18 41.64 47.04
Dividend Yield		 2.02% 1.01% 0.77% 0.74% 1.26% 0.99% 0.97% 0.90% 1.11% 0.99% 0.69%
Earnings Yield		 3.26% 2.71% 2.42% 3.00% 5.26% 26.30% 2.67% 2.52% 2.08% 2.40% 2.13%
Enterprise Value to Invested Capital (EV/IC)		 2.05 5.14 6.53 7.80 4.72 0.31 4.39 5.42 4.91 5.96 9.45
Enterprise Value to Revenue (EV/Rev)		 1.43 3.31 4.63 5.27 3.68 0.30 6.23 6.46 5.64 5.94 8.82
Enterprise Value to EBITDA (EV/EBITDA)		 10.51 17.52 20.87 21.25 12.08 1.35 21.87 21.05 25.37 25.02 31.39
Enterprise Value to EBIT (EV/EBIT)		 16.05 22.73 25.50 25.37 13.95 1.69 28.32 27.47 34.39 31.56 37.21
Enterprise Value to NOPAT (EV/NOPAT)		 25.84 33.17 38.72 30.94 17.06 2.03 36.09 34.90 45.26 41.02 47.94
Enterprise Value to Operating Cash Flow (EV/OCF)		 18.41 22.67 24.41 23.24 19.90 2.50 23.16 28.42 35.92 31.25 43.96
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 37.58 0.00 43.29 45.06 0.00 0.00 35.60 48.43 55.53 69.41
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.22 0.00 0.00 0.00 0.50
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.21 0.00 0.00 0.00 0.50
Financial Leverage		 -0.27 -0.32 -0.31 -0.33 -0.37 -0.29 -0.07 -0.14 -0.29 -0.33 -0.37
Leverage Ratio		 1.22 1.18 1.16 1.16 1.16 1.23 1.38 1.28 1.15 1.16 1.41
Compound Leverage Factor		 1.22 1.18 1.17 1.17 1.19 1.27 1.32 1.21 1.20 1.26 1.54
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 18.06% 0.00% 0.00% 0.00% 33.22%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.19% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 16.87% 0.00% 0.00% 0.00% 33.22%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 81.94% 100.00% 100.00% 100.00% 66.78%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 1.03 0.00 0.00 0.00 2.71
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.30 0.00 0.00 0.00 -2.14
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.96 0.00 0.00 0.00 2.71
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 1.70 0.00 0.00 0.00 4.15
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.00 0.00 0.00 -3.26
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 1.59 0.00 0.00 0.00 4.15
Altman Z-Score		 7.18 15.46 20.35 23.07 13.74 2.89 7.55 18.41 15.88 17.33 7.68
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 4.84 5.61 5.63 6.09 4.76 4.42 3.75 6.41 6.39 6.51 13.14
Quick Ratio		 2.94 3.80 3.58 4.30 3.22 2.36 1.85 4.11 4.13 4.36 10.77
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -3.74 6.90 -2.13 12 8.61 -16 -46 28 19 21 28
Operating Cash Flow to CapEx		 469.51% 506.55% 594.72% 356.37% 638.70% 377.00% 3,628.78% 719.01% 1,070.35% 505.86% 633.78%
Free Cash Flow to Firm to Interest Expense		 -747.32 0.00 -151.98 584.60 4,307.22 0.00 -34.99 12.63 0.00 0.00 136.33
Operating Cash Flow to Interest Expense		 1,102.40 0.00 1,206.86 1,088.95 9,753.00 0.00 26.56 15.82 0.00 0.00 215.24
Operating Cash Flow Less CapEx to Interest Expense		 867.60 0.00 1,003.93 783.38 8,226.00 0.00 25.83 13.62 0.00 0.00 181.28
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.94 0.91 0.93 0.88 0.76 0.69 0.59 0.57 0.54 0.59 0.49
Accounts Receivable Turnover		 6.65 6.88 7.09 7.16 6.87 7.26 7.16 7.88 7.76 8.22 7.98
Inventory Turnover		 1.51 1.52 1.51 1.49 1.31 1.12 1.06 1.16 1.18 1.23 1.12
Fixed Asset Turnover		 11.21 11.27 11.86 9.89 7.97 8.10 8.66 9.62 9.25 9.76 9.45
Accounts Payable Turnover		 19.19 19.40 20.30 21.86 19.32 17.24 17.91 22.41 21.65 20.02 25.10
Days Sales Outstanding (DSO)		 54.91 53.05 51.51 51.01 53.11 50.27 50.96 46.31 47.05 44.43 45.76
Days Inventory Outstanding (DIO)		 241.30 240.85 242.15 245.74 279.47 326.71 345.20 313.85 309.90 297.65 325.52
Days Payable Outstanding (DPO)		 19.02 18.81 17.98 16.70 18.90 21.17 20.38 16.29 16.86 18.23 14.54
Cash Conversion Cycle (CCC)		 277.20 275.09 275.67 280.05 313.68 355.81 375.78 343.87 340.09 323.84 356.74
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 50 50 63 68 82 115 184 184 186 193 205
Invested Capital Turnover		 1.56 1.57 1.57 1.54 1.40 1.19 0.87 0.84 0.87 1.02 1.10
Increase / (Decrease) in Invested Capital		 7.66 0.92 13 4.90 14 33 68 0.57 1.32 7.32 13
Enterprise Value (EV)		 101 259 412 531 388 36 806 998 912 1,149 1,940
Market Capitalization		 120 287 437 573 436 68 795 1,067 994 1,254 2,072
Book Value per Share		 $3.93 $4.30 $4.71 $5.70 $6.65 $74.39 $8.48 $11.64 $12.19 $13.38 $15.00
Tangible Book Value per Share		 $2.52 $2.97 $2.92 $4.03 $4.43 $41.83 $2.35 $6.20 $7.08 $8.55 $10.48
Total Capital		 68 78 88 110 130 148 211 254 268 298 505
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 38 0.00 0.00 0.00 168
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 36 0.00 0.00 0.00 168
Net Debt		 -19 -27 -24 -42 -48 -33 11 -70 -83 -105 -132
Capital Expenditures (CapEx)		 1.17 2.26 2.84 6.42 3.05 3.76 0.96 4.88 2.37 7.27 6.96
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 20 20 24 25 26 39 45 48 54 60 72
Debt-free Net Working Capital (DFNWC)		 39 48 49 67 74 71 72 118 136 165 372
Net Working Capital (NWC)		 39 48 49 67 74 71 69 118 136 165 372
Net Nonoperating Expense (NNE)		 0.01 0.06 0.06 -0.00 -0.19 -0.41 1.11 1.68 -0.50 -2.11 -3.58
Net Nonoperating Obligations (NNO)		 -19 -27 -24 -42 -48 -33 11 -70 -83 -105 -132
Total Depreciation and Amortization (D&A)		 3.33 3.39 3.59 4.06 4.32 5.42 8.40 11 9.43 9.52 9.67
Debt-free, Cash-free Net Working Capital to Revenue		 27.93% 25.99% 27.21% 25.24% 24.89% 32.89% 34.51% 31.16% 33.23% 30.83% 32.69%
Debt-free Net Working Capital to Revenue		 54.22% 61.03% 54.45% 66.55% 70.34% 60.77% 55.36% 76.46% 84.38% 85.13% 169.01%
Net Working Capital to Revenue		 54.22% 61.03% 54.45% 66.55% 70.34% 60.77% 53.43% 76.46% 84.38% 85.13% 169.01%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.24 $0.44 $0.57 $0.91 $1.18 $0.91 $1.05 $1.27 $0.94 $1.36 $1.96
Adjusted Weighted Average Basic Shares Outstanding		 16.61M 17.76M 18.49M 18.96M 19.43M 19.81M 20.25M 21.16M 21.98M 22.22M 22.45M
Adjusted Diluted Earnings per Share		 $0.23 $0.42 $0.55 $0.86 $1.13 $0.88 $1.04 $1.25 $0.93 $1.34 $1.93
Adjusted Weighted Average Diluted Shares Outstanding		 17.01M 18.32M 19.24M 20.03M 20.24M 20.33M 20.48M 21.48M 22.17M 22.42M 22.78M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 17.51M 18.34M 18.67M 19.28M 18.67M 20.18M 20.53M 21.93M 22.10M 22.34M 22.56M
Normalized Net Operating Profit after Tax (NOPAT)		 4.40 7.57 11 17 17 18 22 29 22 28 40
Normalized NOPAT Margin		 6.18% 9.67% 11.95% 17.03% 15.84% 14.95% 16.98% 18.51% 13.90% 14.66% 18.40%
Pre Tax Income Margin		 8.89% 14.58% 18.22% 20.92% 26.94% 18.49% 21.15% 22.20% 17.01% 20.40% 25.87%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 1,264.80 0.00 1,155.36 997.52 13,907.50 0.00 21.72 16.36 0.00 0.00 254.30
NOPAT to Interest Expense		 785.48 0.00 760.81 817.84 11,376.72 0.00 17.05 12.88 0.00 0.00 197.37
EBIT Less CapEx to Interest Expense		 1,030.00 0.00 952.43 691.95 12,380.50 0.00 20.99 14.16 0.00 0.00 220.34
NOPAT Less CapEx to Interest Expense		 550.68 0.00 557.88 512.26 9,849.72 0.00 16.31 10.68 0.00 0.00 163.41
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 58.95% 36.67% 31.38% 24.33% 23.73% 37.56% 36.26% 34.70% 53.25% 41.35% 32.65%
Augmented Payout Ratio		 64.34% 40.10% 34.32% 28.86% 26.96% 41.37% 38.95% 37.68% 56.36% 44.18% 36.55%

Quarterly Metrics and Ratios for LeMaitre Vascular

This table displays calculated financial ratios and metrics derived from LeMaitre Vascular's official financial filings.

Metric Q3 2022 Q4 2022 Q1 2023 Q2 2023 Q3 2023 Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024
Period end date 9/30/2022 12/31/2022 3/31/2023 6/30/2023 9/30/2023 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024
Growth Metrics		 - - - - - - - - - -
Revenue Growth		 1.72% 3.67% 18.99% 19.02% 21.48% 19.36% 13.60% 11.44% 15.63% 13.98%
EBITDA Growth		 -31.14% -13.74% -4.49% 52.88% 38.65% 32.42% 44.67% 40.04% 38.56% 18.25%
EBIT Growth		 -34.63% -11.33% -5.57% 79.09% 52.80% 40.40% 58.36% 49.10% 48.48% 22.24%
NOPAT Growth		 -22.00% -22.47% -0.91% 102.42% 28.42% 51.90% 54.64% 47.85% 43.63% 34.26%
Net Income Growth		 -16.11% -8.87% 0.03% 130.38% 37.50% 50.44% 63.69% 46.04% 48.51% 32.12%
EPS Growth		 -16.67% -7.41% 0.00% 125.00% 32.00% 52.00% 62.96% 44.44% 48.48% 26.32%
Operating Cash Flow Growth		 -47.84% -19.36% -51.62% 28.71% 61.03% 163.58% 122.51% -19.14% 20.49% 41.28%
Free Cash Flow Firm Growth		 -46.74% -37.32% -107.87% -149.52% -152.41% -91.35% 756.54% 53.23% -77.27% -805.02%
Invested Capital Growth		 -0.25% 0.72% 3.35% 6.20% 5.57% 3.94% 3.65% 6.60% 8.12% 6.49%
Revenue Q/Q Growth		 -7.31% 4.93% 14.95% 6.46% -5.40% 3.10% 9.40% 4.43% -1.84% 1.64%
EBITDA Q/Q Growth		 4.95% 17.38% 1.67% 22.07% -4.82% 12.10% 11.08% 18.16% -5.83% -4.32%
EBIT Q/Q Growth		 9.35% 24.93% 1.33% 29.37% -6.70% 14.79% 14.29% 21.81% -7.09% -5.50%
NOPAT Q/Q Growth		 48.94% -7.89% 18.00% 25.04% -5.51% 8.96% 20.13% 19.55% -8.21% 1.85%
Net Income Q/Q Growth		 55.22% 3.13% 7.34% 34.07% -7.36% 12.84% 16.80% 19.61% -5.79% 0.39%
EPS Q/Q Growth		 56.25% 0.00% 8.00% 33.33% -8.33% 15.15% 15.79% 18.18% -5.77% -2.04%
Operating Cash Flow Q/Q Growth		 -20.61% -44.47% -44.10% 422.29% -0.67% -9.11% -52.81% 89.80% 48.01% 6.57%
Free Cash Flow Firm Q/Q Growth		 -24.50% -37.33% -108.70% -1,102.96% 20.10% 110.34% 560.74% -185.69% -202.86% 58.89%
Invested Capital Q/Q Growth		 -0.46% 2.20% 4.12% 0.25% -1.05% 0.63% 3.83% 3.11% 0.36% -0.89%
Profitability Metrics		 - - - - - - - - - -
Gross Margin		 64.24% 63.62% 65.60% 64.02% 65.00% 68.05% 68.56% 68.88% 67.82% 69.26%
EBITDA Margin		 21.04% 23.54% 20.82% 23.87% 24.02% 26.11% 26.51% 30.00% 28.78% 27.09%
Operating Margin		 15.76% 17.01% 16.73% 18.86% 19.36% 20.88% 22.20% 25.75% 23.98% 23.07%
EBIT Margin		 15.08% 17.95% 15.82% 19.23% 18.96% 21.11% 22.06% 25.73% 24.35% 22.64%
Profit (Net Income) Margin		 13.98% 13.74% 12.83% 16.16% 15.82% 17.32% 18.49% 21.18% 20.32% 20.07%
Tax Burden Percent		 88.74% 72.16% 75.34% 78.48% 76.35% 74.83% 77.26% 76.27% 76.57% 79.77%
Interest Burden Percent		 104.49% 106.08% 107.63% 107.08% 109.29% 109.61% 108.49% 107.91% 109.00% 111.14%
Effective Tax Rate		 11.26% 27.84% 24.66% 21.52% 23.65% 25.17% 22.74% 23.73% 23.43% 20.23%
Return on Invested Capital (ROIC)		 12.33% 10.73% 11.22% 13.95% 14.70% 15.98% 17.43% 20.19% 19.62% 20.32%
ROIC Less NNEP Spread (ROIC-NNEP)		 12.33% 9.95% 11.08% 13.13% 14.15% 15.10% 16.68% 19.34% 18.65% 19.54%
Return on Net Nonoperating Assets (RNNOA)		 -3.55% -2.91% -3.16% -4.02% -4.55% -5.01% -5.42% -6.52% -6.65% -7.29%
Return on Equity (ROE)		 8.78% 7.83% 8.06% 9.93% 10.16% 10.97% 12.01% 13.67% 12.97% 13.03%
Cash Return on Invested Capital (CROIC)		 12.15% 10.18% 7.28% 6.64% 8.19% 10.93% 12.29% 11.00% 11.17% 14.04%
Operating Return on Assets (OROA)		 8.17% 9.62% 8.82% 10.89% 11.06% 12.43% 13.18% 15.34% 14.59% 11.08%
Return on Assets (ROA)		 7.57% 7.36% 7.15% 9.15% 9.23% 10.20% 11.05% 12.63% 12.18% 9.82%
Return on Common Equity (ROCE)		 8.78% 7.83% 8.06% 9.93% 10.16% 10.97% 12.01% 13.67% 12.97% 13.03%
Return on Equity Simple (ROE_SIMPLE)		 8.11% 0.00% 7.53% 8.89% 9.45% 0.00% 11.01% 11.79% 12.48% 0.00%
Net Operating Profit after Tax (NOPAT)		 5.46 5.03 5.93 7.42 7.01 7.64 9.17 11 10 10
NOPAT Margin		 13.98% 12.28% 12.60% 14.80% 14.78% 15.62% 17.15% 19.64% 18.36% 18.40%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.79% 0.14% 0.82% 0.56% 0.88% 0.75% 0.84% 0.97% 0.79%
Return On Investment Capital (ROIC_SIMPLE)		 - 1.87% - - - 2.56% - - - 2.03%
Cost of Revenue to Revenue		 35.76% 36.38% 34.40% 35.98% 35.00% 31.95% 31.44% 31.12% 32.18% 30.74%
SG&A Expenses to Revenue		 18.52% 16.93% 16.85% 15.41% 16.32% 17.27% 16.85% 15.79% 16.30% 17.04%
R&D to Revenue		 8.87% 8.68% 8.23% 9.01% 8.91% 8.90% 7.65% 7.67% 6.67% 6.49%
Operating Expenses to Revenue		 48.48% 46.61% 48.88% 45.16% 45.63% 47.17% 46.36% 43.13% 43.84% 46.19%
Earnings before Interest and Taxes (EBIT)		 5.88 7.35 7.45 9.64 8.99 10 12 14 13 13
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 8.21 9.64 9.80 12 11 13 14 17 16 15
Valuation Ratios		 - - - - - - - - - -
Price to Book Value (P/BV)		 4.18 3.71 4.09 5.19 4.16 4.21 4.79 5.77 6.30 6.14
Price to Tangible Book Value (P/TBV)		 7.42 6.38 6.89 8.47 6.70 6.59 7.30 8.58 9.16 8.80
Price to Revenue (P/Rev)		 6.82 6.15 6.63 8.32 6.48 6.48 7.39 8.96 9.80 9.42
Price to Earnings (P/E)		 51.54 48.18 54.36 58.42 44.08 41.64 43.48 48.92 50.51 47.04
Dividend Yield		 0.98% 1.11% 1.01% 0.80% 1.24% 0.99% 0.88% 0.73% 0.67% 0.69%
Earnings Yield		 1.94% 2.08% 1.84% 1.71% 2.27% 2.40% 2.30% 2.04% 1.98% 2.13%
Enterprise Value to Invested Capital (EV/IC)		 5.58 4.91 5.39 7.14 5.77 5.96 6.83 8.38 9.48 9.45
Enterprise Value to Revenue (EV/Rev)		 6.32 5.64 6.15 7.81 5.95 5.94 6.84 8.41 9.22 8.82
Enterprise Value to EBITDA (EV/EBITDA)		 27.01 25.37 29.34 34.92 25.82 25.02 27.20 31.41 33.01 31.39
Enterprise Value to EBIT (EV/EBIT)		 36.88 34.39 39.93 45.62 33.05 31.56 33.58 38.04 39.39 37.21
Enterprise Value to NOPAT (EV/NOPAT)		 46.81 45.26 51.82 58.16 43.53 41.02 43.80 49.74 51.88 47.94
Enterprise Value to Operating Cash Flow (EV/OCF)		 38.40 35.92 45.36 54.04 36.73 31.25 34.60 46.43 49.47 43.96
Enterprise Value to Free Cash Flow (EV/FCFF)		 45.84 48.43 75.25 110.81 72.35 55.53 56.58 78.65 88.14 69.41
Leverage & Solvency		 - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50
Financial Leverage		 -0.29 -0.29 -0.29 -0.31 -0.32 -0.33 -0.32 -0.34 -0.36 -0.37
Leverage Ratio		 1.16 1.15 1.14 1.16 1.16 1.16 1.15 1.14 1.15 1.41
Compound Leverage Factor		 1.21 1.23 1.23 1.24 1.26 1.27 1.25 1.23 1.25 1.57
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 33.22%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 33.22%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 66.78%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.71
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.14
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.71
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.15
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -3.26
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.15
Altman Z-Score		 17.61 15.68 18.14 22.37 17.55 17.08 21.24 27.21 29.07 7.44
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - -
Current Ratio		 6.53 6.39 6.89 6.75 6.28 6.51 7.57 8.36 7.74 13.14
Quick Ratio		 4.26 4.13 4.45 4.51 4.16 4.36 5.17 5.66 5.32 10.77
Cash Flow Metrics		 - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 5.92 3.71 -0.32 -3.88 -3.10 0.32 2.12 -1.82 -5.50 -2.26
Operating Cash Flow to CapEx		 1,596.09% 323.57% 107.00% 424.65% 1,122.79% 840.19% 370.15% 512.51% 853.05% 742.76%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Efficiency Ratios		 - - - - - - - - - -
Asset Turnover		 0.54 0.54 0.56 0.57 0.58 0.59 0.60 0.60 0.60 0.49
Accounts Receivable Turnover		 8.09 7.76 7.24 7.39 8.44 8.22 7.19 7.19 7.59 7.98
Inventory Turnover		 1.20 1.18 1.18 1.25 1.27 1.23 1.17 1.13 1.11 1.12
Fixed Asset Turnover		 9.90 9.25 9.42 9.58 10.11 9.76 9.65 9.28 9.41 9.45
Accounts Payable Turnover		 18.51 21.65 21.33 19.83 18.21 20.02 20.76 24.09 22.40 25.10
Days Sales Outstanding (DSO)		 45.11 47.05 50.44 49.39 43.25 44.43 50.76 50.79 48.10 45.76
Days Inventory Outstanding (DIO)		 303.18 309.90 308.87 292.28 288.53 297.65 311.23 322.92 327.94 325.52
Days Payable Outstanding (DPO)		 19.72 16.86 17.11 18.41 20.05 18.23 17.58 15.15 16.29 14.54
Cash Conversion Cycle (CCC)		 328.57 340.09 342.19 323.26 311.74 323.84 344.41 358.56 359.75 356.74
Capital & Investment Metrics		 - - - - - - - - - -
Invested Capital		 182 186 193 194 192 193 200 206 207 205
Invested Capital Turnover		 0.88 0.87 0.89 0.94 0.99 1.02 1.02 1.03 1.07 1.10
Increase / (Decrease) in Invested Capital		 -0.46 1.32 6.26 11 10 7.32 7.06 13 16 13
Enterprise Value (EV)		 1,012 912 1,041 1,383 1,105 1,149 1,368 1,730 1,963 1,940
Market Capitalization		 1,092 994 1,122 1,474 1,202 1,254 1,476 1,843 2,087 2,072
Book Value per Share		 $11.89 $12.19 $12.41 $12.81 $12.96 $13.38 $13.81 $14.24 $14.73 $15.00
Tangible Book Value per Share		 $6.70 $7.08 $7.36 $7.85 $8.06 $8.55 $9.06 $9.57 $10.14 $10.48
Total Capital		 261 268 274 284 289 298 309 320 331 505
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 168
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 168
Net Debt		 -80 -83 -81 -90 -97 -105 -108 -113 -124 -132
Capital Expenditures (CapEx)		 0.46 1.26 2.13 2.80 1.05 1.28 1.37 1.88 1.67 2.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 50 54 60 58 56 60 68 74 74 72
Debt-free Net Working Capital (DFNWC)		 130 136 141 149 153 165 176 187 198 372
Net Working Capital (NWC)		 130 136 141 149 153 165 176 187 198 372
Net Nonoperating Expense (NNE)		 0.00 -0.60 -0.11 -0.68 -0.49 -0.83 -0.71 -0.86 -1.07 -0.93
Net Nonoperating Obligations (NNO)		 -80 -83 -81 -90 -97 -105 -108 -113 -124 -132
Total Depreciation and Amortization (D&A)		 2.33 2.29 2.35 2.33 2.40 2.44 2.38 2.38 2.43 2.48
Debt-free, Cash-free Net Working Capital to Revenue		 31.19% 33.23% 35.39% 33.00% 30.25% 30.83% 33.95% 36.12% 34.68% 32.69%
Debt-free Net Working Capital to Revenue		 80.96% 84.38% 83.27% 83.89% 82.54% 85.13% 88.13% 91.12% 92.84% 169.01%
Net Working Capital to Revenue		 80.96% 84.38% 83.27% 83.89% 82.54% 85.13% 88.13% 91.12% 92.84% 169.01%
Earnings Adjustments		 - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.25 $0.25 $0.27 $0.36 $0.34 $0.39 $0.44 $0.53 $0.50 $0.49
Adjusted Weighted Average Basic Shares Outstanding		 21.98M 21.98M 22.11M 22.21M 22.26M 22.22M 22.37M 22.46M 22.48M 22.45M
Adjusted Diluted Earnings per Share		 $0.25 $0.25 $0.27 $0.36 $0.33 $0.38 $0.44 $0.52 $0.49 $0.48
Adjusted Weighted Average Diluted Shares Outstanding		 22.22M 22.17M 22.27M 22.45M 22.48M 22.42M 22.57M 22.73M 22.84M 22.78M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 22.00M 22.10M 22.16M 22.26M 22.26M 22.34M 22.45M 22.47M 22.48M 22.56M
Normalized Net Operating Profit after Tax (NOPAT)		 5.46 5.03 6.16 7.56 7.01 7.64 9.17 11 10 10
Normalized NOPAT Margin		 13.98% 12.28% 13.09% 15.08% 14.78% 15.62% 17.15% 19.64% 18.36% 18.40%
Pre Tax Income Margin		 15.75% 19.04% 17.03% 20.59% 20.73% 23.14% 23.93% 27.76% 26.54% 25.16%
Debt Service Ratios		 - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Payout Ratios		 - - - - - - - - - -
Dividend Payout Ratio		 50.25% 53.25% 54.97% 46.45% 44.31% 41.35% 38.11% 35.60% 33.63% 32.65%
Augmented Payout Ratio		 52.98% 56.36% 58.21% 49.12% 46.79% 44.18% 41.17% 38.35% 36.13% 36.55%

Frequently Asked Questions About LeMaitre Vascular's Financials

When does LeMaitre Vascular's fiscal year end?

According to the most recent income statement we have on file, LeMaitre Vascular's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has LeMaitre Vascular's net income changed over the last 10 years?

LeMaitre Vascular's net income appears to be on an upward trend, with a most recent value of $44.04 million in 2024, rising from $3.92 million in 2014. The previous period was $30.11 million in 2023. View LeMaitre Vascular's forecast to see where analysts expect LeMaitre Vascular to go next.

What is LeMaitre Vascular's operating income?
LeMaitre Vascular's total operating income in 2024 was $52.26 million, based on the following breakdown:
  • Total Gross Profit: $150.90 million
  • Total Operating Expenses: $98.65 million
How has LeMaitre Vascular revenue changed over the last 10 years?

Over the last 10 years, LeMaitre Vascular's total revenue changed from $71.10 million in 2014 to $219.86 million in 2024, a change of 209.2%.

How much debt does LeMaitre Vascular have?

LeMaitre Vascular's total liabilities were at $214.53 million at the end of 2024, a 338.9% increase from 2023, and a 1,514.8% increase since 2014.

How much cash does LeMaitre Vascular have?

In the past 10 years, LeMaitre Vascular's cash and equivalents has ranged from $11.79 million in 2019 to $27.45 million in 2015, and is currently $25.61 million as of their latest financial filing in 2024.

How has LeMaitre Vascular's book value per share changed over the last 10 years?

Over the last 10 years, LeMaitre Vascular's book value per share changed from 3.93 in 2014 to 15.00 in 2024, a change of 282.1%.


Related Companies

This page (NASDAQ:LMAT) was last updated on 5/6/2025 by MarketBeat.com Staff
From Our Partners
Elon’s Terrifying Warning Forces Trump To Take Action
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored
Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...
Porter & Company | Sponsored
Shocking AI play that’s beats Nvidia by a country mile
You’ve seen the headlines about Nvidia. Now Tim Sykes is sounding the alarm — because what CEO Jensen Huang is...
Timothy Sykes | Sponsored
Altucher: Turn $900 into $108,000 in just 12 months?
We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.
Paradigm Press | Sponsored
Most traders are panicking. We’re cashing in
Most traders are panicking right now. Bitcoin’s dropping. Altcoins are bleeding. The stock market’s a mess....
Crypto Swap Profits | Sponsored
Trump’s Bitcoin Reserve is No Accident…
Crypto policy is changing fast… Smart investors are positioning themselves to benefit. And it's all happeni...
Crypto 101 Media | Sponsored
Elon Musk is all in on these robots …
Robots — built by Nvidia. Forbes says this could be " a $24 trillion opportunity for investors." Huang s...
Weiss Ratings | Sponsored
Buffett’s favorite chart just hit 209% – here’s what that means for gold
A Historic Gold Announcement Is About to Rock Wall Street For months, sharp-eyed analysts have watched the ...
Golden Portfolio | Sponsored